Transferring your manufacturing site | What to consider regarding biocompatibility
Whether for economic or strategic reasons, medical device manufacturers often outsource their production to another site or external company. In…
Congenius
Whether for economic or strategic reasons, medical device manufacturers often outsource their production to another site or external company. In…
Congenius
On 27 December 2022, Directive (EU) 2022/2555 on measures for a high common level of cybersecurity across the EU (NIS…
Congenius
As we snap back into action for 2023, here’s a quick roundup of some literature from the MDCG that you…
Congenius
At the EPSCO Council meeting last Friday 9 December, the EU Commission presented a legislative initiative to urgently amend the…
Congenius
The idea of breaking down a complex problem into smaller, more manageable challenges is a well-established concept. In software design,…
Congenius
It’s undeniable that adherence to EU MDR requirements remains a challenge for everyone involved. And with the complexity of the…
Congenius
Adherence to quality requirements for plastic components in MedTech is becoming increasingly important as MDR and IVDR dictate more stringent…
Congenius
Many existing medical devices operate on legacy systems, which makes them difficult to maintain and vulnerable to manipulation by hackers.…
Congenius